Gordon Dunn
Financieel Directeur/CFO bij QUOIN PHARMACEUTICALS, LTD.
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Gordon Dunn
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
NS Asset Management LLP
 NS Asset Management LLP Investment ManagersFinance N S Asset Management LLP (NAM) is the asset management subsidiary of NS Holdings LLP ultimately held by Man Group Plc (LSE: EMG, ADR: MNGPY) in Great Britain. Established in 2003, the firm provides investment management services across a range of investment strategies to corporations, governments, pension plans, insurance companies, endowments foundations and high net-worth individuals. NAM is based in London and has additional offices in Singapore, Hong Kong, Tokyo and New York.
38
| Extinct | Investment Managers | 38 |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland.
11
| Extinct | Pharmaceuticals: Major | 11 |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
| Public Company | Pharmaceuticals: Major | 7 | |
Innocoll, Inc.
 Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA.
5
| Extinct | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gordon Dunn via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
Fuisz Technologies Ltd.
 Fuisz Technologies Ltd. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd. is a company that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. The company is based in Chantilly, VA. Fuisz Technologies was acquired by Biovail Corp. on November 12, 1999 for $145.48 million. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| WEST PHARMACEUTICAL SERVICES, INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Janus Henderson Investors UK Ltd.
 Janus Henderson Investors UK Ltd. Investment ManagersFinance Janus Henderson Investors UK Ltd. (JHI UK) is the wholly-owned global asset management subsidiary of Janus Henderson UK (Holdings) Ltd., ultimately held by Janus Henderson Group Plc (LON: 0RPW; NYSE: JHG) in Great Britain. The firm was founded in 1934 and formerly known as Henderson Global Investors Ltd. Headquartered in London, JHI UK is a client-centric, sustainable and responsible investor which provides investment management services to individuals, private banks, third party distributors, insurance companies, pension funds, government bodies, investment trusts, charities and corporate entities. | Investment Managers | Portfolio Manager-Equities | |
First Sentier Investors (UK) IM Ltd.
 First Sentier Investors (UK) IM Ltd. Investment ManagersFinance First Sentier Investors (UK) IM Ltd. (FSIIM) is the wholly-owned, Great Britain-based specialist asset management subsidiary of S.I. Holdings Ltd., ultimately held by Mitsubishi UFJ Financial Group, Inc. (TYO: 8306) in Japan. Headquartered in Edinburgh, the firm was founded in 1970 and formerly known as First State Investment Management (UK) Ltd. FSIIM provides discretionary investment management and portfolio management services to a range of institutional clients and funds. | Investment Managers | Portfolio Manager-Equities | |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer | |
GLG Partners LP
 GLG Partners LP Investment ManagersFinance GLG Partners LP (GLG) is an independent alternative investment management firm headquartered in London, UK. The firm was founded in 1995 by Noam Gottesman, Pierre Lagrange and Jonathan Green as a hedge fund division within Lehman Brothers Holdings Inc. GLG offers advisory or sub-advisory services to non-US and US institutional managed accounts and pooled investment vehicles on either a discretionary or non-discretionary basis. | Investment Managers | Analyst-Equity Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Analyst-Equity Analyst-Equity Analyst-Equity | |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Graduate Degree | |
Troy Asset Management Ltd.
 Troy Asset Management Ltd. Investment ManagersFinance Troy Asset Management Ltd. (Troy) is a privately owned, independent investment boutique headquartered in London, UK. The firm was founded in 2000 by the late Lord Weinstock and Sebastian Lyon. Troy manages a range of funds and investment trusts for family offices, wealth managers, investment advisers, charities and endowments. Their management is incentivized through personal investment in the funds. | Investment Managers | Director of Research - Equity Portfolio Manager-Equities | |
| University of Cambridge | College/University | Graduate Degree | |
BlueCrest Capital Management (UK) LLP
 BlueCrest Capital Management (UK) LLP Investment ManagersFinance BlueCrest Capital Management (UK) LLP (BCM-UK) is an independent, Great Britain-based alternative asset management firm headquartered in London. The firm was founded in 2009 by Michael Platt and Bill Reeves to manage their flagship fund, BlueCrest Capital International. In 2015, they transitioned to a Private Investment Partnership and returned client capital. BCM-UK currently manages assets solely on behalf of their partners and employees. | Investment Managers | Portfolio Manager-Fixed Income Portfolio Manager-Equities | |
| Iowa State University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree | |
Levine, Blaszak, Block & Boothby LLP
 Levine, Blaszak, Block & Boothby LLP Miscellaneous Commercial ServicesCommercial Services Levine, Blaszak, Block & Boothby LLP provides telecommunications and IT law services. The company specializes in negotiating custom network service agreements, wireless agreements, network outsourcings, and related transactions on behalf of large users and information technology companies. Its services include telecom & information technology transactions, regulatory work and litigation, and dispute resolution. The company was founded in 1993 and is headquartered in Washington, DC | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
The District of Columbia Bar
 The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| ECHO THERAPEUTICS, INC. | Medical Specialties | President | |
| Start-up Law | Corporate Officer/Principal | ||
BNP Paribas Asset Management UK Ltd.
 BNP Paribas Asset Management UK Ltd. Investment ManagersFinance BNP Paribas Asset Management UK Ltd. (BNPP AM UK) is an asset management firm headquartered in London, UK. The firm was founded in 1990 and is a wholly owned subsidiary of BNP Paribas Asset Management Holding SA, itself a subsidiary of BNP Paribas SA (EPA: BNP, ADR: BNPQY) in France. BNPP AM UK provides customized investment management services to institutional clients, wholesale clients and collective investment schemes. | Investment Managers | Head-Equity Investments Portfolio Manager-Equities Portfolio Manager-Equities Director of Research - Equity | |
| VISTAGEN THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Armour Therapeutics, Inc.
 Armour Therapeutics, Inc. Medical/Nursing ServicesHealth Services Armour Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development of a new class of anti-hormone therapeutics for the treatment of reproductive tissue-based cancers. The company was founded by Josh Silvertown in 2009 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Director/Board Member | |
Innocoll Pharmaceuticals Ltd.
 Innocoll Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Innocoll Pharmaceuticals Ltd. engages in pharmaceutical preparations. The company was founded on June 1, 2005 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| The University of Maryland Francis King Carey School of Law | College/University | Graduate Degree | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member Director of Finance/CFO | |
| INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Executive Officer Director/Board Member Director of Finance/CFO | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
Berg LLC
 Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| First State Infrastructure Managers (International) Ltd. | Corporate Officer/Principal | ||
| Sonoran Biosciences, Inc. | Director/Board Member Director/Board Member | ||
| JANUS HENDERSON GROUP PLC | Investment Managers | Chief Investment Officer | |
Quoin Pharmaceuticals, Inc.
 Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 32 |
| Verenigd Koninkrijk | 14 |
| Ierland | 3 |
| Zwitserland | 3 |
| Canada | 2 |
Sectoraal
| Health Technology | 24 |
| Finance | 11 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 164 |
| Corporate Officer/Principal | 105 |
| Independent Dir/Board Member | 48 |
| Portfolio Manager-Equities | 43 |
| Chairman | 35 |
Sterkste connecties
| Insiders | |
|---|---|
| Dennis Langer | 40 |
| Anthony Zook | 24 |
| Jonathan Symonds | 24 |
| Shumeet Banerji | 23 |
| Shawn Singh | 22 |
| Tony H. Wild | 22 |
| David Brennan | 19 |
| Anthony Culverwell | 18 |
| Maryellen C. Herringer | 17 |
| James Tursi | 17 |
| Michael Sember | 16 |
| Michael Myers | 15 |
| Joe Wiley | 14 |
| Joseph Cooper | 13 |
| Michael John Paul Marks | 12 |
- Beurs
- Insiders
- Gordon Dunn
- Bedrijfsconnecties
